Spotlight on the NLRP3 inflammasome pathway

Spotlight on the NLRP3 inflammasome pathway

Marine Groslambert,1–5 Bénédicte F Py1–5 1Centre International de Recherche en Infectiologie (CIRI), Université de Lyon, Lyon, France; 2INSERM, U1111, Lyon, France; 3Ecole Normale Supérieure de Lyon, Lyon, France; 4Centre International...

Full description

Bibliographic Details
Main Authors:	Groslambert M, Py BF
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-09-01
Series:	Journal of Inflammation Research
Subjects:	inflammation NLRP3 inflammasome post-translational modifications
Online Access:	https://www.dovepress.com/spotlight-on-the-nlrp3-inflammasome-pathway-peer-reviewed-article-JIR

Similar Items

NLRP3 Ubiquitination—A New Approach to Target NLRP3 Inflammasome Activation
by: Mahbuba Akther, et al.
Published: (2021-08-01)

Etude de l'impact fonctionnel des modifications post-traductionnelles dans l'activation de l'inflammasome NLRP3
by: Groslambert, Marine
Published: (2019)

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
by: Nathan Kelley, et al.
Published: (2019-07-01)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
by: Yang Gyun Kim, et al.
Published: (2019-11-01)

NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis
by: Wan Z, et al.
Published: (2019-09-01)

The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging
by: Allison K. Meyers, et al.
Published: (2020-07-01)

Inhibiting the NLRP3 Inflammasome
by: Lina Y. El-Sharkawy, et al.
Published: (2020-11-01)

Interplay Between NLRP3 Inflammasome and Autophagy
by: Monika Biasizzo, et al.
Published: (2020-10-01)

Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia
by: Joyce de Cassia Rosa de Jesus, et al.
Published: (2021-09-01)

Role of the NLRP3 Inflammasome in Preeclampsia
by: Koumei Shirasuna, et al.
Published: (2020-02-01)

Targeting the NLRP3 Inflammasome in Glaucoma
by: Sophie Coyle, et al.
Published: (2021-08-01)

MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies
by: Gulcin Tezcan, et al.
Published: (2019-05-01)

NLRP3 Inflammasome in Cardiovascular Disease: David`s Stone against Goliath?
by: Serban BALANESCU, et al.
Published: (2021-09-01)

NLRP3 Inflammasome Sequential Changes in Staphylococcus aureus-Induced Mouse Model of Acute Rhinosinusitis
by: Yan-Jun Wang, et al.
Published: (2014-09-01)

Activation and Inhibition of the NLRP3 Inflammasome by RNA Viruses
by: Choudhury SM, et al.
Published: (2021-03-01)

NLRP3 Inflammasome Signaling as a Link Between HIV-1 Infection and Atherosclerotic Cardiovascular Disease
by: Caroline Mullis, et al.
Published: (2020-06-01)

Amentoflavone Affects Epileptogenesis and Exerts Neuroprotective Effects by Inhibiting NLRP3 Inflammasome
by: Shikuo Rong, et al.
Published: (2019-07-01)

Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer
by: Sonia Missiroli, et al.
Published: (2021-05-01)

Role of the NLRP3 inflammasome in autoimmune diseases
by: Zhe Li, et al.
Published: (2020-10-01)

The NLRP3 inflammasome: an emerging therapeutic target for chronic pain
by: Ruixiang Chen, et al.
Published: (2021-03-01)

Olive Leaf Extract (OleaVita) Suppresses Inflammatory Cytokine Production and NLRP3 Inflammasomes in Human Placenta
by: Yasuaki Kaneko, et al.
Published: (2019-04-01)

The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases
by: Burak Ibrahim Arioz, et al.
Published: (2021-06-01)

Zerumbone Suppresses the LPS-Induced Inflammatory Response and Represses Activation of the NLRP3 Inflammasome in Macrophages
by: Chia-Cheng Su, et al.
Published: (2021-05-01)

The Role of NLRP1, NLRP3, and AIM2 Inflammasomes in Psoriasis: Review
by: Magdalena Ciążyńska, et al.
Published: (2021-05-01)

Inflammasome activation controlled by the interplay between post-translational modifications: emerging drug target opportunities
by: Zhu Liang, et al.
Published: (2021-02-01)

Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease Models
by: Biswadeep Das, et al.
Published: (2021-08-01)

Neurodegenerative Disease and the NLRP3 Inflammasome
by: Jonathan A. Holbrook, et al.
Published: (2021-03-01)

Protective Effect of Piplartine against LPS-Induced Sepsis through Attenuating the MAPKs/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation
by: Chi-Han Huang, et al.
Published: (2021-06-01)

NLRP3 inflammasome: the core mechanism and potential target of inflammatory response in Alzheimer's disease
by: Jian-quan SHI, et al.
Published: (2020-01-01)

NLRP3 Inflammasome Activation by Viroporins of Animal Viruses
by: Hui-Chen Guo, et al.
Published: (2015-06-01)

New Insights into the Role of NLRP3 Inflammasome in Pathogenesis and Treatment of Chronic Obstructive Pulmonary Disease
by: Zhang J, et al.
Published: (2021-08-01)

NLRP3 inflammasome activation mediates terahertz exposure-induced skin aseptic inflammation in mice
by: GAO Peng, et al.
Published: (2020-12-01)

Lactic Acid Fermentation Is Required for NLRP3 Inflammasome Activation
by: Hsin-Chung Lin, et al.
Published: (2021-03-01)

Tanshinone IIA ameliorates acute lung injury by inhibition of the NLRP3 inflammasome
by: Chen Tianyu, et al.
Published: (2019-01-01)

Exposure to nickel oxide nanoparticles induces pulmonary inflammation through NLRP3 inflammasome activation in rats
by: Cao Z, et al.
Published: (2016-07-01)

Regulation of NLRP3 inflammasome: Biochemistry and beyond
by: Buelvas Jiménez, Neudo, et al.
Published: (2015-04-01)

Implication of the NLRP3 Inflammasome in Bovine Age-Related Sarcopenia
by: Davide De Biase, et al.
Published: (2021-03-01)

Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia
by: Zheng Fan, et al.
Published: (2017-12-01)

Teuvincenone F Suppresses LPS-Induced Inflammation and NLRP3 Inflammasome Activation by Attenuating NEMO Ubiquitination
by: Xibao Zhao, et al.
Published: (2017-08-01)

Regulation of NLRP3 Inflammasome by Phosphorylation
by: Nan Song, et al.
Published: (2018-10-01)